Chou, Hung-HsuehHung-HsuehChouFereday, SianSianFeredayDeFazio, AnnaAnnaDeFazioChang, Chih-LongChih-LongChangBowtell, DavidDavidBowtellHENG-CHENG HSUTraficante, NadiaNadiaTraficanteJeong, Soo YoungSoo YoungJeongWEN-FANG CHENGAriyarantne, DinukaDinukaAriyarantneTung, TeresaTeresaTungRajadhyaksha, VirajVirajRajadhyakshaLee, Won-HeeWon-HeeLeeBrown, DavidDavidBrownKim, Byoung-GieByoung-GieKim2023-01-192023-01-192023-0120050380https://scholars.lib.ntu.edu.tw/handle/123456789/627462The real-world INFORM study analyzed sociodemographics, treatment patterns and clinical outcomes for patients with newly diagnosed advanced epithelial ovarian cancer (EOC) in Australia, South Korea (S.Korea) and Taiwan preceding incorporation of poly(ADP-ribose) polymerase inhibitors into clinical practice.enAdjuvant Chemotherapy; Bevacizumab; Maintenance Therapy; Neoadjuvant Chemotherapy; Ovarian Cancer; SurgeryContrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwanjournal article10.3802/jgo.2023.34.e3363668102-s2.0-85145064111https://api.elsevier.com/content/abstract/scopus_id/85145064111